多蛋白和3D聚合酶蛋白在Sf9细胞中的表达及对肠病毒A71B5(泰国株)的免疫原性

Q2 Pharmacology, Toxicology and Pharmaceutics
Nipatha Issaro, Aphisak Kongkaew, Akanitt Jittmittraphap, Pornsawan Leaungwutiwong, W. Nimlamool, M. N. Takuathung
{"title":"多蛋白和3D聚合酶蛋白在Sf9细胞中的表达及对肠病毒A71B5(泰国株)的免疫原性","authors":"Nipatha Issaro, Aphisak Kongkaew, Akanitt Jittmittraphap, Pornsawan Leaungwutiwong, W. Nimlamool, M. N. Takuathung","doi":"10.7324/japs.2023.93192","DOIUrl":null,"url":null,"abstract":"Enterovirus 71 B5 subgenotype (EV-A71B5) is a primary human pathogen of hand, foot, and mouth disease. In this study, we aimed to prepare a novel recombinant protein polyprotein (P1) and 3D polymerase (3D p ° l ) protein of EV-A71B5 and determine mice immunogenicity and neutralization activity against EV-A71 of the B5 subgenotype commonly found in Thailand. Using a dual promoter system and investigating its expression in Sf9 cells, we constructed a novel recombinant protein containing P1 and 3D p ° l protein. The purified P1-3D p ° l was observed by western blotting and transmission electron microscopy (TEM) to determine the particle size. Furthermore, we determined the immunogenicity and neutralization activity against EV-A71 of the B5 subgenotype using concatenation of Bagg and Albino (BALB/c) mice. The results revealed that P1-3D p ° l was expressed in Sf9 cells. We used TEM to visualize the particle size of P1-3D p ° l to be approximately 33 nm. P1-3D p ° l had the potential to elicit the production of immunoglobulin G and immunoglobulin M antibodies and the T helper type 1-dominant cytokine interferon-γ after immunizing BALB/c mice and inducing neutralization antibodies against EV-A71B5. Our results demonstrated that Sf9 cells successfully produced P1-3D p ° l , which can leverage immune efficacy in BALB/c mice and be used to develop vaccines against the EV-A71B5 strain prevalent in Thailand.","PeriodicalId":15126,"journal":{"name":"journal of applied pharmaceutical science","volume":"2 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Expression of polyprotein and 3D polymerase protein in Sf9 cells and immunogenicity against enterovirus A71B5 (Thailand strain)\",\"authors\":\"Nipatha Issaro, Aphisak Kongkaew, Akanitt Jittmittraphap, Pornsawan Leaungwutiwong, W. Nimlamool, M. N. Takuathung\",\"doi\":\"10.7324/japs.2023.93192\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Enterovirus 71 B5 subgenotype (EV-A71B5) is a primary human pathogen of hand, foot, and mouth disease. In this study, we aimed to prepare a novel recombinant protein polyprotein (P1) and 3D polymerase (3D p ° l ) protein of EV-A71B5 and determine mice immunogenicity and neutralization activity against EV-A71 of the B5 subgenotype commonly found in Thailand. Using a dual promoter system and investigating its expression in Sf9 cells, we constructed a novel recombinant protein containing P1 and 3D p ° l protein. The purified P1-3D p ° l was observed by western blotting and transmission electron microscopy (TEM) to determine the particle size. Furthermore, we determined the immunogenicity and neutralization activity against EV-A71 of the B5 subgenotype using concatenation of Bagg and Albino (BALB/c) mice. The results revealed that P1-3D p ° l was expressed in Sf9 cells. We used TEM to visualize the particle size of P1-3D p ° l to be approximately 33 nm. P1-3D p ° l had the potential to elicit the production of immunoglobulin G and immunoglobulin M antibodies and the T helper type 1-dominant cytokine interferon-γ after immunizing BALB/c mice and inducing neutralization antibodies against EV-A71B5. Our results demonstrated that Sf9 cells successfully produced P1-3D p ° l , which can leverage immune efficacy in BALB/c mice and be used to develop vaccines against the EV-A71B5 strain prevalent in Thailand.\",\"PeriodicalId\":15126,\"journal\":{\"name\":\"journal of applied pharmaceutical science\",\"volume\":\"2 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"journal of applied pharmaceutical science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7324/japs.2023.93192\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"journal of applied pharmaceutical science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7324/japs.2023.93192","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

摘要

肠病毒71B5亚基因型(EV-A71B5)是人类手足口病的主要病原体。在这项研究中,我们旨在制备EV-A71B5的新型重组蛋白多蛋白(P1)和3D聚合酶(3D p°l)蛋白,并测定小鼠对泰国常见的B5亚基因型EV-A71的免疫原性和中和活性。利用双启动子系统并研究其在Sf9细胞中的表达,我们构建了一个含有P1和3D p°l蛋白的重组蛋白。通过western blotting和透射电镜(TEM)观察纯化的P1-3D p°l的粒径。此外,我们利用Bagg和Albino (BALB/c)小鼠的连接,测定了B5亚基因型对EV-A71的免疫原性和中和活性。结果显示,P1-3D p°1在Sf9细胞中表达。我们使用TEM观察到P1-3D p°l的粒径约为33 nm。在免疫BALB/c小鼠并诱导针对EV-A71B5的中和抗体后,P1-3D p°l有可能引发免疫球蛋白G和免疫球蛋白M抗体以及T辅助型1优势细胞因子干扰素-γ的产生。我们的研究结果表明,Sf9细胞成功产生P1-3D p°1,可以利用BALB/c小鼠的免疫功效,并用于开发针对泰国流行的EV-A71B5菌株的疫苗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Expression of polyprotein and 3D polymerase protein in Sf9 cells and immunogenicity against enterovirus A71B5 (Thailand strain)
Enterovirus 71 B5 subgenotype (EV-A71B5) is a primary human pathogen of hand, foot, and mouth disease. In this study, we aimed to prepare a novel recombinant protein polyprotein (P1) and 3D polymerase (3D p ° l ) protein of EV-A71B5 and determine mice immunogenicity and neutralization activity against EV-A71 of the B5 subgenotype commonly found in Thailand. Using a dual promoter system and investigating its expression in Sf9 cells, we constructed a novel recombinant protein containing P1 and 3D p ° l protein. The purified P1-3D p ° l was observed by western blotting and transmission electron microscopy (TEM) to determine the particle size. Furthermore, we determined the immunogenicity and neutralization activity against EV-A71 of the B5 subgenotype using concatenation of Bagg and Albino (BALB/c) mice. The results revealed that P1-3D p ° l was expressed in Sf9 cells. We used TEM to visualize the particle size of P1-3D p ° l to be approximately 33 nm. P1-3D p ° l had the potential to elicit the production of immunoglobulin G and immunoglobulin M antibodies and the T helper type 1-dominant cytokine interferon-γ after immunizing BALB/c mice and inducing neutralization antibodies against EV-A71B5. Our results demonstrated that Sf9 cells successfully produced P1-3D p ° l , which can leverage immune efficacy in BALB/c mice and be used to develop vaccines against the EV-A71B5 strain prevalent in Thailand.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
journal of applied pharmaceutical science
journal of applied pharmaceutical science Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
2.20
自引率
0.00%
发文量
224
期刊介绍: Journal of Applied Pharmaceutical Science (JAPS) is a monthly, international, open access, journal dedicated to various disciplines of pharmaceutical and allied sciences. JAPS publishes manuscripts (Original research and review articles Mini-reviews, Short communication) on original work, either experimental or theoretical in the following areas; Pharmaceutics & Biopharmaceutics Novel & Targeted Drug Delivery Nanotechnology & Nanomedicine Pharmaceutical Chemistry Pharmacognosy & Ethnobotany Phytochemistry Pharmacology & Toxicology Pharmaceutical Biotechnology & Microbiology Pharmacy practice & Hospital Pharmacy Pharmacogenomics Pharmacovigilance Natural Product Research Drug Regulatory Affairs Case Study & Full clinical trials Biomaterials & Bioactive polymers Analytical Chemistry Physical Pharmacy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信